TM4SF1 was once reported to be involved in tumor progression and metastasis by promoting the activation of PKCα 26; therefore, we speculated that the TM4SF1 protein derived from breast cancer cells or platelets themselves would induce PKCα activation in platelets. Here, TM4SF1 is linked to breast carcinoma.